Results 11 to 20 of about 741,639 (316)

Prostatitis [PDF]

open access: yesNephrology Dialysis Transplantation, 2001
Prostatitis is a common condition that accounts for a significant number of visits to both the emergency department and the urologist. The precise pathogenic mechanism of prostatitis is not known. The most prevalent theory is that reflux of urine from the urethra into the intraprostatic ducts promotes ascending infection and leads to chemical or ...
W E, Lummus, I, Thompson
  +9 more sources

Usefulness of grayscale values measuring hypoechoic lesions for predicting prostate cancer: An experimental pilot study [PDF]

open access: yes, 2022
Background: To ensure reproducibility and representativeness of hypoechoic lesions in transrectal ultrasonography (TRUS), we used grayscale values and evaluated their usefulness in predicting prostate cancer (PCA).
이광석, 유정우
core   +1 more source

Prostatitis [PDF]

open access: yesHospital Medicine, 1999
Prostatitis, especially chronic prostatitis, is sometimes regarded as an obscure, ill-defined condition, perhaps because the anatomical location of the gland and ill-defined symptoms make diagnosis difficult. Treatment may appear time consuming and tiresome for doctor and patient, but by following established principles, diagnosis is often simple and ...
Theodorou, C, Becopoulos, T
openaire   +5 more sources

Androgen deprivation therapy may reduce the risk of primary open-angle glaucoma in patients with prostate cancer: a nationwide population-based cohort study [PDF]

open access: yes, 2021
Background: We evaluated the risk of developing primary open-angle glaucoma (POAG) according to androgen deprivation therapy (ADT) status in patients with prostate cancer.
조강수, 김민, 하지수, 이혜선
core   +1 more source

Clinical studies investigating the use of leuprorelin for prostate cancer in Asia [PDF]

open access: yes, 2020
Background: Leuprorelin is a well-established treatment for prostate cancer (PCa); however, there is limited information on its use in Asian males. This review of English language publications between January 2000 and 2016 describes the outcomes of ...
정병하
core   +1 more source

Clinical experience with active surveillance protocol using regular magnetic resonance imaging instead of regular repeat biopsy for monitoring: A study at a high-volume center in Korea [PDF]

open access: yes, 2021
Background: Here, we report the experience of a multiparameter magnetic resonance imaging (MRI)-based active surveillance (AS) protocol that did not include performing a repeat biopsy after the diagnosis of prostate cancer by prostate biopsy or ...
이광석, 정병하, 구교철
core   +1 more source

Prevention and early detection of prostate cancer. [PDF]

open access: yes, 2014
Prostate cancer is a common malignancy in men and the worldwide burden of this disease is rising. Lifestyle modifications such as smoking cessation, exercise, and weight control offer opportunities to reduce the risk of developing prostate cancer.
Culig, Zoran   +166 more
core   +1 more source

Long-term outcome among men with conservatively treated localised prostate cancer. [PDF]

open access: yes, 2006
Optimal management of clinically localised prostate cancer presents unique challenges, because of its highly variable and often indolent natural history.
Kattan, M W   +25 more
core   +1 more source

Association between DNA methylation of HSPB1 and death in low Gleason score prostate cancer. [PDF]

open access: yes, 2012
BACKGROUND: Heat shock protein 27 (Hsp-27) encoded by gene HSPB1 is a critical regulator of the behavioral phenotype of human prostate cancer (PCa) cells, enhanced expression being associated with highly aggressive disease and poor clinical outcome.
M A Thorat   +30 more
core   +1 more source

Small extracellular vesicle-mediated ITGB6 siRNA delivery downregulates the αVβ6 integrin and inhibits adhesion and migration of recipient prostate cancer cells

open access: yesCancer Biology & Therapy, 2022
The αVβ6 integrin, an epithelial-specific cell surface receptor absent in normal prostate and expressed during prostate cancer (PrCa) progression, is a therapeutic target in many cancers.
Shiv Ram Krishn   +10 more
doaj   +1 more source

Home - About - Disclaimer - Privacy